title: Comments on the three papers by the FDA/CDER research team on the regulatory perspective of the missing data problem.
abstract: This communication comments on the three papers by the FDA CDER research team on the regulatory perspective of the missing data problem. The focus is on two topics: causal estimand and sensitivity analysis. Copyright © 2016 John Wiley & Sons, Ltd.
authors.affiliation: Department of Biostatistics, Rutgers School of Public Health, Rutgers University, The State University of New Jersey, Piscataway, New Jersey, 08854, U.S.A.
authors.forename: Weichung Joe
authors.initials: WJ
authors.lastname: Shih
mesh_terms: D003627:Data Interpretation, Statistical; D006801:Humans; D012106:Research; D012107:Research Design; D013223:Statistics as Topic; D014481:United States; D014486:United States Food and Drug Administration